Begin with maize seedlings growing under controlled conditions to serve as the host.
Next, take Agrobacterium tumefaciens, a plant-pathogenic bacterium.
The engineered bacteria carry a T-DNA construct encoding a recombinant viral genome. This genome contains an inserted gene fragment designed to silence a target maize gene.
Inject the bacteria just above the coleoptilar node, the lowest node on the plant, until the suspension fills the coleoptile, ensuring delivery to internal tissues.
At the injection site, the bacteria transfer the T-DNA carrying the viral genome into maize cells, where it is transcribed into viral RNA that moves into the cytoplasm.
The RNA replicates and triggers viral protein production, forming new viral particles that spread systemically to establish infection.
The viral RNA carrying the desired gene fragment activates the plant’s RNA interference machinery, degrading specific maize mRNAs and silencing the target gene.
This results in visible alterations in phenotypes regulated by the target gene as the infected plants grow, such as necrotic lesion formation, confirming successful gene silencing.
Use 4 to 7 day old maize seedlings for injecting Agrobacterium. Assemble the syringe and needle. Gently inject the bacterial suspension 2-3 millimeters above the coleoptilular node until it fills up the coleoptile, or is visible in the whorl, depending on the growth stage of the plants.
Inject all seedlings and change the syringe and needles for injecting each construct. Confirm phenotypic infection by observing lesions from silencing the control genes, lesion mimic 22, or phytoene desaturase on the leaves.